Brainsway Ltd. (BWAY) Form 6-K — Aug 12, 2026
BrainsWay reported record second quarter 2026 revenue of $17.1 million, up 35% year-over-year from $12.6 million, with net income rising 34% to $2.7 million ($0.07 basic and diluted EPS). This marked the company's second consecutive quarter of approximately 35% revenue growth. Profitability improved sharply: Adjusted EBITDA more than doubled year-over-year to $3.5 million with margin expanding to 20%, operating income rose over 300% to $2.4 million, and the company generated $6.3 million of operating cash flow. Record shipments of 125 Deep TMS systems (up 42%) lifted the installed base to approximately 1,949, while remaining performance obligations grew 30% to $80.4 million.
Key figures
- Eps
- $0.07 basic / $0.07 diluted (Q2 2026) vs $0.05 basic / $0.05 diluted (Q2 2025)
- Revenue
- $17.1 million (Q2 2026 record; vs $12.6 million Q2 2025)
- Guidance
- FY2026 revenue raised to $68M-$70M (from $66M-$68M), ~30-34% growth vs 2025; operating income 13.5%-14% of revenue (from 13%-14%); Adjusted EBITDA raised to $13M-$14M (from $12M-$14M), ~90-100% growth over 2025
- Net Income
- $2.7 million (Q2 2026) vs $2.0 million (Q2 2025), +34%
- Revenue Yoy
- +35%
- Cash Position
- $62.4 million in cash, cash equivalents and restricted cash as of June 30, 2026 (~+6% vs March 31, 2026)
- Installed Base
- approximately 1,949 Deep TMS systems
- Operating Margin
- 14% (vs 5% prior year)
- Six Month Revenue
- $32.6 million (vs $24.2 million in H1 2025)
- Systems Shipped Yoy
- +42%
- Systems Shipped Q2
- 125
- Pcl5 Score Reduction
- mean 52% reduction
- Adjusted EBITDAMargin
- 20% (vs 11% prior year)
- Operating Cash Flow Q2
- $6.3 million
- Adjusted EBITDA Q2 2026
- $3.5 million, +141% YoY (vs $1.5 million)
- Operating Income Q2 2026
- $2.4 million, up more than 300% YoY (vs $0.6 million)
- Ptsd Response Rate real World Data
- 83.5%
- Remaining Performance Obligations
- $80.4 million, +30% YoY
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.